Crossmark

Efficacy and safety of tyrosine kinase inhibitors with thoracic radiotherapy for patients with oncogene-mutated non-small cell lung cancer: a meta-analysis

Crossref DOI link: https://doi.org/10.1186/s13014-024-02538-y

Published Online: 2024-11-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Wenxia

Wu, Peiye

Liang, Zhanpeng

Li, Luzhen

Chen, Yunqi

Zhang, Wenjing

Zhang, Huatang

Fang, Cantu
License Information

Text and Data Mining valid from 2024-11-06

Version of Record valid from 2024-11-06
More Information

Article History

Received: 9 April 2024

Accepted: 13 October 2024

First Online: 6 November 2024

Declarations

:

: Not applicable.

: Not applicable for the section.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below